| 2026-03-20 02:10:44 |
statusModule.statusVerifiedDate: 2025-07 |
statusModule.statusVerifiedDate: 2026-03 |
| 2026-03-20 02:10:44 |
statusModule.primaryCompletionDateStruct.date: 2026-02 |
statusModule.primaryCompletionDateStruct.date: 2026-09-30 |
| 2026-03-20 02:10:44 |
statusModule.completionDateStruct.date: 2026-02 |
statusModule.completionDateStruct.date: 2027-01-01 |
| 2026-03-20 02:10:44 |
statusModule.lastUpdateSubmitDate: 2025-07-30 |
statusModule.lastUpdateSubmitDate: 2026-03-17 |
| 2026-03-20 02:10:44 |
statusModule.lastUpdatePostDateStruct.date: 2025-08-01 |
statusModule.lastUpdatePostDateStruct.date: 2026-03-19 |
| 2026-05-26 02:38:39 |
referencesModule.references.[0]citation: Wang X, Kapoor VN, Chin DJ, Klakamp SL, Baruffaldi F, Mohan JF, Haines R, Dulak A, Panduro M, Ren Y, Masia R, Hill JA, LaVallee TM, Rajasekaran N. CHS-114: an afucosylated anti-CCR8 monoclonal antibody that selectively depletes intratumoral Treg cells and induces antitumor immune responses. Mol Cancer Ther. 2025 Dec 22. doi: 10.1158/1535-7163.MCT-25-0367. Online ahead of print. |
referencesModule.references.[0]citation: Wang X, Kapoor VN, Chin DJ, Klakamp SL, Baruffaldi F, Mohan JF, Haines R, Dulak A, Panduro M, Ren Y, Masia R, Hill JA, LaVallee TM, Rajasekaran N. CHS-114: An Afucosylated Anti-CCR8 Monoclonal Antibody that Selectively Depletes Intratumoral Treg Cells and Induces Antitumor Immune Responses. Mol Cancer Ther. 2026 May 4;25(5):685-700. doi: 10.1158/1535-7163.MCT-25-0367. |
| 2026-07-28 00:26:03 |
statusModule.statusVerifiedDate: 2026-03 |
statusModule.statusVerifiedDate: 2026-07 |
| 2026-07-28 00:26:03 |
statusModule.lastUpdateSubmitDate: 2026-03-17 |
statusModule.lastUpdateSubmitDate: 2026-07-13 |
| 2026-07-28 00:26:03 |
statusModule.lastUpdatePostDateStruct.date: 2026-03-19 |
statusModule.lastUpdatePostDateStruct.date: 2026-07-14 |
| 2026-07-28 00:26:03 |
contactsLocationsModule.overallOfficials.[0]name: Koho Izuka, MD |
contactsLocationsModule.overallOfficials.[0]name: Study Director |
| 2026-07-28 00:26:03 |
contactsLocationsModule.overallOfficials.[0]affiliation: Coherus BioSciences |
contactsLocationsModule.overallOfficials.[0]affiliation: Coherus Oncology |
| 2026-07-28 00:26:03 |
contactsLocationsModule.locations.[0]status: RECRUITING |
contactsLocationsModule.locations.[0]status: WITHDRAWN |
| 2026-07-28 00:26:03 |
contactsLocationsModule.locations.[1]status: RECRUITING |
contactsLocationsModule.locations.[1]status: WITHDRAWN |
| 2026-07-28 00:26:03 |
contactsLocationsModule.locations.[3]status: RECRUITING |
contactsLocationsModule.locations.[3]status: WITHDRAWN |
| 2026-07-28 00:26:03 |
contactsLocationsModule.locations.[5]status: RECRUITING |
contactsLocationsModule.locations.[5]status: WITHDRAWN |
| 2026-07-28 00:26:03 |
root['contactsLocationsModule']['locations'][0]['contacts'] (Removed) |
- |
| 2026-07-28 00:26:03 |
root['contactsLocationsModule']['locations'][1]['contacts'] (Removed) |
- |
| 2026-07-28 00:26:03 |
root['contactsLocationsModule']['locations'][3]['contacts'] (Removed) |
- |
| 2026-07-28 00:26:03 |
root['contactsLocationsModule']['locations'][5]['contacts'] (Removed) |
- |